AI-generated summary
This randomized clinical trial compared low-level laser therapy with calcium hydroxide intracanal medication in 46 patients with symptomatic apical periodontitis after root canal treatment. The authors report no significant differences between the two groups in postoperative pain, percussion pain at one week, or the reduction of substance P and IL-8 in periapical fluid. The authors state these findings are within the study's limitations.
- Participants
- 46
- Who or what was studied
- Patients aged 20-55 with symptomatic apical periodontitis and mature, single-canalled permanent teeth
- Limits stated in the abstract
- The abstract states that two patients were lost to follow-up and that conclusions apply only within the study's stated limitations, without detailing them.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
Post-operative pain following root canal therapy remains a prevalent clinical issue, especially in cases of symptomatic apical periodontitis, where inflammatory mediators such as interleukin-8 (IL-8) and substance P are critically involved in the pathophysiology. This study aimed to assess and compare the efficacy of LLLT and Calcium Hydroxide (CH) as intracanal medication in alleviating post-operative pain, percussion sensitivity, and in reducing the levels of IL-8 and substance P in periapical exudate one week after root canal instrumentation in patients with symptomatic apical periodontitis. METHODOLOGY: This comparative, parallel-design randomized clinical trial evaluated the effectiveness of low-level laser therapy (LLLT) versus Calcium Hydroxide in managing post-operative pain in 48 patients with symptomatic apical periodontitis. Patients aged 20-55 with mature, single-canalled permanent teeth were randomly assigned (1:1) to either treatment group using computer-generated randomization with concealed allocation. Root canal therapy was performed over two visits, with pre- and post-operative pain and percussion sensitivity recorded at different time intervals. Periapical fluid samples were collected immediately post-instrumentation (PS-1) and after one week (PS-2) to quantify substance P and IL-8 using ELISA. Blinding was maintained for the molecular biologist and the statistician. Data were analyzed using SPSS v25.0.
Results
Two patients were lost to follow-up; therefore, 46 patients were included in the analysis. Statistical analysis revealed no significant differences between the LLLT and Calcium Hydroxide groups in terms of postoperative pain at any assessed time point, nor in percussion pain at 1-week post-instrumentation (p > 0.05). Furthermore, the reduction in substance P and IL-8 concentrations between PS-1 and PS-2 samples did not differ significantly between groups (p = 0.123 and p = 0.385, respectively).
Conclusion
Within the Limitations of this study, it may be concluded that LLLT may be considered a viable single-visit treatment option and an effective alternative to Calcium Hydroxide for the management of Symptomatic Apical Periodontitis, as both demonstrated comparable clinical pain relief and biochemical modulation of IL-8 and Substance P.
Trial Registration Number
NCT04594317 on Clinicaltrials.gov on 13th of oct. 2020.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Trial registration, Blinding. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.